Although the authors did not observe a major impact of rituximab therapy in MM, we would like to draw attention to one patient in their study with 100% CD20 expression who experienced an ongoing 18 ...
Latest U.S. sanction represents fifth for antibody against hematologic cancers. Genentech and Biogen Idec reported receiving an FDA go-ahead for Rituxan® in combination with fludarabine and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results